|
GB145299A
(en)
|
1919-08-14 |
1920-07-02 |
Carl Theodor Thorssell |
Improvements in or relating to apparatus for the production of nitrogen products
|
|
US2234705A
(en)
|
1940-04-12 |
1941-03-11 |
Eastman Kodak Co |
Cellulose organic derivative composition containing esters of monoalkoxy benzoic acids
|
|
US2413258A
(en)
|
1942-07-07 |
1946-12-24 |
United Gas Improvement Co |
Polystyrene-type resins plasticized with high boiling fatty acid alkyl esters
|
|
BR6794063D0
(pt)
|
1966-10-21 |
1973-09-18 |
Minnesota Mining & Mfg |
Processo para preparar perfluoral-quilsulfonamidas n-substituidas e composicoes herbicidas e fitoreguladoras nelas baseadas
|
|
AU7915675A
(en)
|
1974-03-20 |
1976-09-23 |
Bayer Ag |
Alkoxycarbonylphenylureas
|
|
GB1573212A
(en)
|
1976-04-15 |
1980-08-20 |
Technicon Instr |
Immunoassay for gentamicin
|
|
CA1148562A
(en)
*
|
1979-02-22 |
1983-06-21 |
Alfred J. Bird |
Catalyst for the hydrogenation of halogen substituted aromatic nitro compounds
|
|
US4301159A
(en)
|
1980-06-20 |
1981-11-17 |
Shionogi & Co., Ltd. |
N-(Diethylaminoethyl)-2-alkoxy-benzamide derivatives
|
|
AU547405B2
(en)
|
1981-07-08 |
1985-10-17 |
Sanofi |
Amidobenzamides
|
|
US4664504A
(en)
|
1983-01-20 |
1987-05-12 |
Tokyo Shibaura Denki Kabushiki Kaisha |
Image forming apparatus
|
|
US4568649A
(en)
|
1983-02-22 |
1986-02-04 |
Immunex Corporation |
Immediate ligand detection assay
|
|
US4626513A
(en)
|
1983-11-10 |
1986-12-02 |
Massachusetts General Hospital |
Method and apparatus for ligand detection
|
|
AU567140B2
(en)
|
1984-01-06 |
1987-11-12 |
Shionogi & Co., Ltd. |
Sulphonamido-benzamide derivatives
|
|
EP0154734B1
(en)
|
1984-03-15 |
1990-08-29 |
Immunex Corporation |
Immediate ligand detection assay, a test kit and its formation
|
|
IT1196133B
(it)
|
1984-06-06 |
1988-11-10 |
Ausonia Farma Srl |
Derivati furanici con attivita' antiulcera
|
|
US4714693A
(en)
|
1986-04-03 |
1987-12-22 |
Uop Inc. |
Method of making a catalyst composition comprising uniform size metal components on carrier
|
|
DE3642315A1
(de)
|
1986-12-11 |
1988-06-23 |
Boehringer Mannheim Gmbh |
Neue pyrrolobenzimidazole, verfahren zu ihrer herstellung sowie arzneimittel
|
|
US5688655A
(en)
|
1988-02-10 |
1997-11-18 |
Ict Pharmaceuticals, Inc. |
Method of screening for protein inhibitors and activators
|
|
US6054270A
(en)
|
1988-05-03 |
2000-04-25 |
Oxford Gene Technology Limited |
Analying polynucleotide sequences
|
|
US5700637A
(en)
|
1988-05-03 |
1997-12-23 |
Isis Innovation Limited |
Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays
|
|
US5658775A
(en)
|
1988-05-17 |
1997-08-19 |
Sloan-Kettering Institute For Cancer Research |
Double copy retroviral vector
|
|
JP2528706B2
(ja)
|
1988-05-30 |
1996-08-28 |
ゼリア新薬工業株式会社 |
ジヒドロピリジン化合物の製剤組成物
|
|
EP0432216A1
(en)
|
1988-09-01 |
1991-06-19 |
Whitehead Institute For Biomedical Research |
Recombinant retroviruses with amphotropic and ecotropic host ranges
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
US5800992A
(en)
|
1989-06-07 |
1998-09-01 |
Fodor; Stephen P.A. |
Method of detecting nucleic acids
|
|
US5527681A
(en)
|
1989-06-07 |
1996-06-18 |
Affymax Technologies N.V. |
Immobilized molecular synthesis of systematically substituted compounds
|
|
US5143854A
(en)
|
1989-06-07 |
1992-09-01 |
Affymax Technologies N.V. |
Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
|
|
US5744101A
(en)
|
1989-06-07 |
1998-04-28 |
Affymax Technologies N.V. |
Photolabile nucleoside protecting groups
|
|
FR2649979B1
(fr)
*
|
1989-07-20 |
1992-01-17 |
Rhone Poulenc Chimie |
Procede d'hydrogenation de derives halogeno nitroaromatiques en presence d'un derive soufre
|
|
WO1991018088A1
(en)
|
1990-05-23 |
1991-11-28 |
The United States Of America, Represented By The Secretary, United States Department Of Commerce |
Adeno-associated virus (aav)-based eucaryotic vectors
|
|
DE4022414A1
(de)
|
1990-07-13 |
1992-01-16 |
Bayer Ag |
Substituierte pyrrolo-pyridine
|
|
US5958930A
(en)
|
1991-04-08 |
1999-09-28 |
Duquesne University Of The Holy Ghost |
Pyrrolo pyrimidine and furo pyrimidine derivatives
|
|
EP0580860B2
(en)
|
1991-04-16 |
2004-12-15 |
Nippon Shinyaku Company, Limited |
Method of manufacturing solid dispersion
|
|
WO1993002556A1
(en)
|
1991-07-26 |
1993-02-18 |
University Of Rochester |
Cancer therapy utilizing malignant cells
|
|
US5632957A
(en)
|
1993-11-01 |
1997-05-27 |
Nanogen |
Molecular biological diagnostic systems including electrodes
|
|
GB9127531D0
(en)
|
1991-12-31 |
1992-02-19 |
Fujisawa Pharmaceutical Co |
Heterocyclic compound
|
|
FR2687402B1
(fr)
|
1992-02-14 |
1995-06-30 |
Lipha |
Nouveaux azaindoles, procedes de preparation et medicaments les contenant.
|
|
JPH05236997A
(ja)
|
1992-02-28 |
1993-09-17 |
Hitachi Ltd |
ポリヌクレオチド捕捉用チップ
|
|
JPH06135946A
(ja)
|
1992-10-30 |
1994-05-17 |
Otsuka Pharmaceut Co Ltd |
ピラジン誘導体
|
|
AU686115B2
(en)
|
1992-11-02 |
1998-02-05 |
Fujisawa Pharmaceutical Co., Ltd. |
Imidazo (I,2-a) pyridine derivatives as bradykinin antagonists, pharmaceuticals and processes for their preparation
|
|
GB9226855D0
(en)
|
1992-12-23 |
1993-02-17 |
Erba Carlo Spa |
Vinylene-azaindole derivatives and process for their preparation
|
|
US5576319A
(en)
|
1993-03-01 |
1996-11-19 |
Merck, Sharp & Dohme Ltd. |
Pyrrolo-pyridine derivatives
|
|
DE69420394T2
(de)
|
1993-03-01 |
2000-04-13 |
Merck Sharp & Dohme |
Pyrrolopyridinderivate als dopaminrezeptor liganden
|
|
EP0687267B1
(en)
|
1993-03-01 |
1999-09-01 |
MERCK SHARP & DOHME LTD. |
Pyrrolo-pyridine derivatives as ligands of dopamine receptor
|
|
HUT71799A
(en)
|
1993-03-01 |
1996-02-28 |
Merck Sharp & Dohme |
Pyrrolo-pyridine derivatives, pharmaceutical compositions containing the same, process for producing them
|
|
US5840485A
(en)
|
1993-05-27 |
1998-11-24 |
Selectide Corporation |
Topologically segregated, encoded solid phase libraries
|
|
NZ267843A
(en)
|
1993-05-27 |
1997-10-24 |
Selectide Corp |
Libraries of synthetic test compound attached to separate phase synthesis supports
|
|
IT1265057B1
(it)
|
1993-08-05 |
1996-10-28 |
Dompe Spa |
Tropil 7-azaindolil-3-carbossiamidi
|
|
US5631236A
(en)
|
1993-08-26 |
1997-05-20 |
Baylor College Of Medicine |
Gene therapy for solid tumors, using a DNA sequence encoding HSV-Tk or VZV-Tk
|
|
US5426039A
(en)
|
1993-09-08 |
1995-06-20 |
Bio-Rad Laboratories, Inc. |
Direct molecular cloning of primer extended DNA containing an alkane diol
|
|
GB9319297D0
(en)
|
1993-09-17 |
1993-11-03 |
Wellcome Found |
Indole derivatives
|
|
US6045996A
(en)
|
1993-10-26 |
2000-04-04 |
Affymetrix, Inc. |
Hybridization assays on oligonucleotide arrays
|
|
US6468742B2
(en)
|
1993-11-01 |
2002-10-22 |
Nanogen, Inc. |
Methods for determination of single nucleic acid polymorphisms using bioelectronic microchip
|
|
US5965452A
(en)
|
1996-07-09 |
1999-10-12 |
Nanogen, Inc. |
Multiplexed active biologic array
|
|
US5486525A
(en)
|
1993-12-16 |
1996-01-23 |
Abbott Laboratories |
Platelet activating factor antagonists: imidazopyridine indoles
|
|
US5360882A
(en)
|
1994-02-04 |
1994-11-01 |
Isp Investments Inc. |
Eutectic compositions of divinyl imidazolidone and vinyl caprolactam
|
|
EP1195372A1
(en)
|
1994-04-18 |
2002-04-10 |
Mitsubishi Pharma Corporation |
N-heterocyclic substituted benzamide derivatives with antihypertensive activity
|
|
GB9408577D0
(en)
|
1994-04-29 |
1994-06-22 |
Fujisawa Pharmaceutical Co |
New compound
|
|
US5807522A
(en)
|
1994-06-17 |
1998-09-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for fabricating microarrays of biological samples
|
|
GB9412719D0
(en)
|
1994-06-24 |
1994-08-17 |
Erba Carlo Spa |
Substituted azaindolylidene compounds and process for their preparation
|
|
US5763198A
(en)
|
1994-07-22 |
1998-06-09 |
Sugen, Inc. |
Screening assays for compounds
|
|
GB9416189D0
(en)
|
1994-08-10 |
1994-09-28 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
GB9416162D0
(en)
|
1994-08-10 |
1994-09-28 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
DE69515177T2
(de)
|
1994-08-10 |
2000-10-05 |
Merck Sharp & Dohme |
Tetrahydropyridinylmethylderivate von pyrrolo[2,3-b]pyridine
|
|
GB9420521D0
(en)
|
1994-10-12 |
1994-11-30 |
Smithkline Beecham Plc |
Novel compounds
|
|
US5556752A
(en)
|
1994-10-24 |
1996-09-17 |
Affymetrix, Inc. |
Surface-bound, unimolecular, double-stranded DNA
|
|
US5830645A
(en)
|
1994-12-09 |
1998-11-03 |
The Regents Of The University Of California |
Comparative fluorescence hybridization to nucleic acid arrays
|
|
US5837815A
(en)
|
1994-12-15 |
1998-11-17 |
Sugen, Inc. |
PYK2 related polypeptide products
|
|
GB9503400D0
(en)
|
1995-02-21 |
1995-04-12 |
Merck Sharp & Dohme |
Therpeutic agents
|
|
GB2298199A
(en)
|
1995-02-21 |
1996-08-28 |
Merck Sharp & Dohme |
Synthesis of azaindoles
|
|
US5959098A
(en)
|
1996-04-17 |
1999-09-28 |
Affymetrix, Inc. |
Substrate preparation process
|
|
US6117681A
(en)
|
1995-03-29 |
2000-09-12 |
Bavarian Nordic Research Inst. A/S |
Pseudotyped retroviral particles
|
|
GB2299581A
(en)
|
1995-04-07 |
1996-10-09 |
Merck Sharp & Dohme |
3-(Tetrahydropyridin-1-yl-methyl)pyrrolo[2,3-b]pyridine derivatives as ligands for dopamine receptor subtypes
|
|
GB9507291D0
(en)
|
1995-04-07 |
1995-05-31 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
GB9511220D0
(en)
|
1995-06-02 |
1995-07-26 |
Glaxo Group Ltd |
Solid dispersions
|
|
US6110456A
(en)
|
1995-06-07 |
2000-08-29 |
Yale University |
Oral delivery or adeno-associated viral vectors
|
|
US5856174A
(en)
|
1995-06-29 |
1999-01-05 |
Affymetrix, Inc. |
Integrated nucleic acid diagnostic device
|
|
WO1997003967A1
(en)
|
1995-07-22 |
1997-02-06 |
Rhone-Poulenc Rorer Limited |
Substituted aromatic compounds and their pharmaceutical use
|
|
US5866411A
(en)
|
1995-09-08 |
1999-02-02 |
Pedersen; Finn Skou |
Retroviral vector, a replication system for said vector and avian or mammalian cells transfected with said vector
|
|
US5747276A
(en)
|
1995-09-15 |
1998-05-05 |
The Scripps Research Institute |
Screening methods for the identification of novel antibiotics
|
|
WO1997016533A1
(en)
|
1995-10-31 |
1997-05-09 |
The Regents Of The University Of California |
Mammalian artificial chromosomes and methods of using same
|
|
US6022963A
(en)
|
1995-12-15 |
2000-02-08 |
Affymetrix, Inc. |
Synthesis of oligonucleotide arrays using photocleavable protecting groups
|
|
US6013440A
(en)
|
1996-03-11 |
2000-01-11 |
Affymetrix, Inc. |
Nucleic acid affinity columns
|
|
US6025155A
(en)
|
1996-04-10 |
2000-02-15 |
Chromos Molecular Systems, Inc. |
Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
|
|
US5804585A
(en)
|
1996-04-15 |
1998-09-08 |
Texas Biotechnology Corporation |
Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin
|
|
US5908401A
(en)
|
1996-05-08 |
1999-06-01 |
The Aps Organization, Llp |
Method for iontophoretic delivery of antiviral agents
|
|
US5725838A
(en)
|
1996-05-31 |
1998-03-10 |
Resolution Pharmaceuticals, Inc. |
Radiolabeled D4 receptor ligands
|
|
US6057100A
(en)
|
1996-06-07 |
2000-05-02 |
Eos Biotechnology, Inc. |
Oligonucleotide arrays
|
|
CA2248784A1
(en)
|
1996-06-25 |
1997-12-31 |
Takeda Chemical Industries, Ltd. |
Oxazolone derivatives and their use
|
|
SI0956865T2
(sl)
|
1996-08-12 |
2011-04-29 |
Mitsubishi Pharma Corp |
Zdravila, ki obsegajo inhibitor Rho-kinaze
|
|
JPH10130269A
(ja)
|
1996-09-04 |
1998-05-19 |
Nippon Chemiphar Co Ltd |
カルボリン誘導体
|
|
JPH1087629A
(ja)
|
1996-09-18 |
1998-04-07 |
Fujisawa Pharmaceut Co Ltd |
新規イソキノリン誘導体、およびその医薬用途
|
|
DE69728688T2
(de)
|
1996-11-19 |
2004-08-19 |
Amgen Inc., Thousand Oaks |
Aryl und heteroaryl substituierte kondensierte pyrrole als entzündunghemmende mittel
|
|
US6294330B1
(en)
|
1997-01-31 |
2001-09-25 |
Odyssey Pharmaceuticals Inc. |
Protein fragment complementation assays for the detection of biological or drug interactions
|
|
EP0972071A4
(en)
|
1997-03-07 |
2004-04-21 |
Tropix Inc |
TEST ARRANGEMENT FOR PROTEAS INHIBITORS
|
|
US5977131A
(en)
|
1997-04-09 |
1999-11-02 |
Pfizer Inc. |
Azaindole-ethylamine derivatives as nicotinic acetylcholine receptor binding agents
|
|
WO1998047899A1
(en)
|
1997-04-24 |
1998-10-29 |
Ortho-Mcneil Corporation, Inc. |
Substituted pyrrolopyridines useful in the treatment of inflammatory diseases
|
|
US6096718A
(en)
|
1997-06-05 |
2000-08-01 |
Gene Targeting Corp. |
Tissue specific adenovirus vectors for breast cancer treatment
|
|
SG72827A1
(en)
|
1997-06-23 |
2000-05-23 |
Hoffmann La Roche |
Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
|
|
AU8096798A
(en)
|
1997-06-27 |
1999-01-19 |
Resolution Pharmaceuticals Inc. |
Dopamine d4 receptor ligands
|
|
US6235769B1
(en)
|
1997-07-03 |
2001-05-22 |
Sugen, Inc. |
Methods of preventing and treating neurological disorders with compounds that modulate the function of the C-RET receptor protein tyrosine kinase
|
|
US6826296B2
(en)
|
1997-07-25 |
2004-11-30 |
Affymetrix, Inc. |
Method and system for providing a probe array chip design database
|
|
DK0901786T3
(da)
|
1997-08-11 |
2007-10-08 |
Pfizer Prod Inc |
Faste farmaceutiske dispersioner med foröget biotilgængelighed
|
|
US6161776A
(en)
|
1997-08-12 |
2000-12-19 |
Nibco Inc. |
Multi-layered, porous mat turf irrigation apparatus and method
|
|
CA2300940A1
(en)
|
1997-08-15 |
1999-02-25 |
Hyseq, Inc. |
Methods and compositions for detection or quantification of nucleic acid species
|
|
ES2190591T3
(es)
|
1997-09-11 |
2003-08-01 |
Bioventures Inc |
Metodo de producir disposiciones ordenadas de alta densidad.
|
|
US6178384B1
(en)
|
1997-09-29 |
2001-01-23 |
The Trustees Of Columbia University In The City Of New York |
Method and apparatus for selecting a molecule based on conformational free energy
|
|
US6465178B2
(en)
|
1997-09-30 |
2002-10-15 |
Surmodics, Inc. |
Target molecule attachment to surfaces
|
|
NZ505844A
(en)
|
1997-12-22 |
2003-10-31 |
Bayer Ag |
Inhibition of raf kinase using substituted heterocyclic ureas
|
|
US6268387B1
(en)
|
1997-12-23 |
2001-07-31 |
Warner-Lambert Company |
Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
|
|
CA2326140A1
(en)
|
1998-04-02 |
1999-10-14 |
Merck & Co., Inc. |
Antagonists of gonadotropin releasing hormone
|
|
JP2002510629A
(ja)
|
1998-04-02 |
2002-04-09 |
メルク エンド カムパニー インコーポレーテッド |
性腺刺激ホルモン放出ホルモン拮抗薬
|
|
WO1999051233A1
(en)
|
1998-04-02 |
1999-10-14 |
Merck & Co., Inc. |
Antagonists of gonadotropin releasing hormone
|
|
EP1066285A1
(en)
|
1998-04-02 |
2001-01-10 |
Merck & Co., Inc. |
Antagonists of gonadotropin releasing hormone
|
|
EP1071423A1
(en)
|
1998-04-02 |
2001-01-31 |
Merck & Co., Inc. |
Antagonists of gonadotropin releasing hormone
|
|
AU3117899A
(en)
|
1998-04-02 |
1999-10-25 |
Merck & Co., Inc. |
Antagonists of gonadotropin releasing hormone
|
|
EP1068356B8
(en)
|
1998-04-03 |
2007-01-03 |
Adnexus Therapeutics, Inc. |
Addressable protein arrays
|
|
US6048695A
(en)
|
1998-05-04 |
2000-04-11 |
Baylor College Of Medicine |
Chemically modified nucleic acids and methods for coupling nucleic acids to solid support
|
|
CA2319495A1
(en)
|
1998-06-08 |
1999-12-16 |
Advanced Medicine, Inc. |
Multibinding inhibitors of microsomal triglyceride transferase protein
|
|
US6113913A
(en)
|
1998-06-26 |
2000-09-05 |
Genvec, Inc. |
Recombinant adenovirus
|
|
EP1459743B9
(en)
|
1998-08-17 |
2012-08-01 |
Senju Pharmaceutical Co., Ltd. |
Agent for prophylaxis and treatment of glaucoma
|
|
CN1261098C
(zh)
|
1998-08-28 |
2006-06-28 |
西奥斯股份有限公司 |
p38－α激酶的抑制剂
|
|
WO2000012514A1
(en)
|
1998-08-28 |
2000-03-09 |
Astrazeneca Ab |
Novel compounds
|
|
CZ2001959A3
(cs)
|
1998-09-18 |
2001-12-12 |
Basf Aktiengesellschaft |
4-Aminopyrrolopyrimidiny jako inhibitory kinasy
|
|
US6594527B2
(en)
|
1998-09-18 |
2003-07-15 |
Nexmed Holdings, Inc. |
Electrical stimulation apparatus and method
|
|
US6350786B1
(en)
|
1998-09-22 |
2002-02-26 |
Hoffmann-La Roche Inc. |
Stable complexes of poorly soluble compounds in ionic polymers
|
|
US6277628B1
(en)
|
1998-10-02 |
2001-08-21 |
Incyte Genomics, Inc. |
Linear microarrays
|
|
IT1303759B1
(it)
|
1998-11-17 |
2001-02-23 |
Dompe Spa |
Procedimento migliorato per la preparazione di acido 7-azaindolil-3-carbossilico.
|
|
US6277489B1
(en)
|
1998-12-04 |
2001-08-21 |
The Regents Of The University Of California |
Support for high performance affinity chromatography and other uses
|
|
US20010001449A1
(en)
|
1998-12-30 |
2001-05-24 |
Thomas R. Kiliany |
Low-pressure hydrocracking process
|
|
EP1176141A4
(en)
|
1999-03-05 |
2002-08-14 |
Suntory Ltd |
HETEROCYCLIC COMPOUNDS HAVING RECEPTOR ACTIVATION EFFECT $ g (a) 4 $ g (b) 2 OF NICOTINIC ACETYLCHOLINE
|
|
US6792306B2
(en)
|
2000-03-10 |
2004-09-14 |
Biophoretic Therapeutic Systems, Llc |
Finger-mounted electrokinetic delivery system for self-administration of medicaments and methods therefor
|
|
EP1163237B1
(en)
|
1999-03-17 |
2004-05-06 |
AstraZeneca AB |
Amide derivatives
|
|
AR028475A1
(es)
|
1999-04-22 |
2003-05-14 |
Wyeth Corp |
Derivados de azaindol y uso de los mismos para la manufactura de un medicamento para el tratamiento de la depresion.
|
|
US6653309B1
(en)
|
1999-04-26 |
2003-11-25 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of IMPDH enzyme technical field of the invention
|
|
US6221653B1
(en)
|
1999-04-27 |
2001-04-24 |
Agilent Technologies, Inc. |
Method of performing array-based hybridization assays using thermal inkjet deposition of sample fluids
|
|
FR2793793B1
(fr)
|
1999-05-19 |
2004-02-27 |
Adir |
Nouveaux derives dimeriques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
US6492406B1
(en)
|
1999-05-21 |
2002-12-10 |
Astrazeneca Ab |
Pharmaceutically active compounds
|
|
TWI234557B
(en)
|
1999-05-26 |
2005-06-21 |
Telik Inc |
Novel naphthalene ureas as glucose uptake enhancers
|
|
US7049312B1
(en)
|
1999-06-03 |
2006-05-23 |
Abbott Gmbh & Co. Kg |
Benzothiazinone and benzoxazinone compounds
|
|
IL147757A0
(en)
|
1999-07-30 |
2002-08-14 |
Abbott Gmbh & Co Kg |
2-pyrazolin-5-ones
|
|
US6653151B2
(en)
|
1999-07-30 |
2003-11-25 |
Large Scale Proteomics Corporation |
Dry deposition of materials for microarrays using matrix displacement
|
|
WO2001024236A1
(en)
|
1999-09-27 |
2001-04-05 |
Infineon Technologies North America Corp. |
Semiconductor structures having a capacitor and manufacturing methods
|
|
GB9924962D0
(en)
|
1999-10-21 |
1999-12-22 |
Mrc Collaborative Centre |
Allosteric sites on muscarinic receptors
|
|
US20010008765A1
(en)
|
1999-12-06 |
2001-07-19 |
Fuji Photo Film Co., Ltd. |
DNA chip and reactive solid carrier
|
|
ES2245955T3
(es)
|
1999-12-21 |
2006-02-01 |
Sugen, Inc. |
7-aza-indolin-2-onas 4-sustituidas y su utilizacion como inhibidores de proteina-quinasa.
|
|
CA2395461C
(en)
|
1999-12-22 |
2010-05-25 |
Sugen, Inc. |
Methods of modulating c-kit tyrosine kinase function with indolinone compounds
|
|
FR2805259B1
(fr)
|
2000-02-17 |
2002-03-29 |
Inst Nat Sante Rech Med |
Nouveaux derives d'aminoacides n-mercaptoacyles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
US20020061892A1
(en)
|
2000-02-22 |
2002-05-23 |
Tao Wang |
Antiviral azaindole derivatives
|
|
JP2001278886A
(ja)
|
2000-03-28 |
2001-10-10 |
Dai Ichi Seiyaku Co Ltd |
ベンゾオキサジン誘導体及びこれを含有する医薬
|
|
GB0007934D0
(en)
|
2000-03-31 |
2000-05-17 |
Darwin Discovery Ltd |
Chemical compounds
|
|
US6335342B1
(en)
|
2000-06-19 |
2002-01-01 |
Pharmacia & Upjohn S.P.A. |
Azaindole derivatives, process for their preparation, and their use as antitumor agents
|
|
EE200200711A
(et)
|
2000-06-26 |
2004-06-15 |
Pfizer Products Inc. |
Pürrolo[2,3-d]pürimidiinühendid kui immunosupressiivsed vahendid
|
|
DE60112306T2
(de)
|
2000-06-26 |
2006-01-12 |
Lilly Icos Llc, Wilmington |
Kondensierte pyrazindionderivate als pde5 inhibitore
|
|
CN1518543A
(zh)
|
2000-08-31 |
2004-08-04 |
�Ʒ� |
吡唑衍生物和它们作为蛋白激酶抑制剂的用途
|
|
US6618625B2
(en)
|
2000-11-29 |
2003-09-09 |
Leon M. Silverstone |
Method and apparatus for treatment of viral diseases
|
|
CA2439366A1
(en)
|
2001-02-27 |
2002-09-06 |
Julie Cahill |
Pharmaceutical formulation comprising bicalutamide
|
|
CN101310771B
(zh)
|
2001-04-11 |
2012-08-08 |
千寿制药株式会社 |
视觉功能障碍改善剂
|
|
AU2002258971A1
(en)
|
2001-04-24 |
2002-11-05 |
Wyeth |
Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-benzodioxan
|
|
GB0114417D0
(en)
|
2001-06-13 |
2001-08-08 |
Boc Group Plc |
Lubricating systems for regenerative vacuum pumps
|
|
EP1267111A1
(en)
|
2001-06-15 |
2002-12-18 |
Dsm N.V. |
Pressurized fluid conduit
|
|
WO2002102783A1
(en)
|
2001-06-19 |
2002-12-27 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
|
US7291639B2
(en)
|
2001-06-20 |
2007-11-06 |
Wyeth |
Aryloxy-acetic acid compounds useful as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
|
|
GB0115109D0
(en)
|
2001-06-21 |
2001-08-15 |
Aventis Pharma Ltd |
Chemical compounds
|
|
SE0102300D0
(sv)
|
2001-06-26 |
2001-06-26 |
Astrazeneca Ab |
Compounds
|
|
US20030091974A1
(en)
|
2001-06-29 |
2003-05-15 |
Alain Moussy |
Method for screening compounds capable of depleting mast cells
|
|
SE0102439D0
(sv)
|
2001-07-05 |
2001-07-05 |
Astrazeneca Ab |
New compounds
|
|
UA75425C2
(en)
|
2001-07-09 |
2006-04-17 |
|
Piperazine oxime derivatives with antagonistic activity to nk-1 receptor, use thereof, a pharmaceutical composition based thereon, a method for producing and a method for producing intermediary compounds
|
|
GB0117583D0
(en)
|
2001-07-19 |
2001-09-12 |
Astrazeneca Ab |
Novel compounds
|
|
US6858860B2
(en)
|
2001-07-24 |
2005-02-22 |
Seiko Epson Corporation |
Apparatus and method for measuring natural period of liquid
|
|
GB0118479D0
(en)
|
2001-07-28 |
2001-09-19 |
Astrazeneca Ab |
Novel compounds
|
|
JP2003073357A
(ja)
|
2001-09-03 |
2003-03-12 |
Mitsubishi Pharma Corp |
アミド化合物を含有するＲｈｏキナーゼ阻害剤
|
|
AU2002334355A1
(en)
|
2001-09-06 |
2003-03-18 |
Prochon Biotech Ltd. |
Protein tyrosine kinase inhibitors
|
|
WO2003028724A1
(en)
|
2001-10-04 |
2003-04-10 |
Smithkline Beecham Corporation |
Chk1 kinase inhibitors
|
|
WO2003037862A1
(fr)
|
2001-10-30 |
2003-05-08 |
Nippon Shinyaku Co., Ltd. |
Derives amide, et medicaments correspondants
|
|
US20030119839A1
(en)
|
2001-12-13 |
2003-06-26 |
Nan-Horng Lin |
Protein kinase inhibitors
|
|
WO2003062236A1
(en)
|
2002-01-22 |
2003-07-31 |
Warner-Lambert Company Llc |
2-(PYRIDIN-2-YLAMINO)-PYRIDO[2,3d]PYRIMIDIN-7-ONES
|
|
US7268230B2
(en)
|
2002-02-01 |
2007-09-11 |
Astrazeneca Ab |
Quinazoline compounds
|
|
US20030236277A1
(en)
|
2002-02-14 |
2003-12-25 |
Kadow John F. |
Indole, azaindole and related heterocyclic pyrrolidine derivatives
|
|
US6884889B2
(en)
|
2002-03-25 |
2005-04-26 |
Bristol-Myers Squibb Co. |
Processes for the preparation of antiviral 7-azaindole derivatives
|
|
CN100338062C
(zh)
|
2002-03-28 |
2007-09-19 |
卫材株式会社 |
作为c－Jun N－末端激酶抑制剂的氮杂吲哚类化合物
|
|
WO2003082868A1
(en)
|
2002-03-28 |
2003-10-09 |
Eisai Co., Ltd. |
7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
|
|
EP1495016A2
(en)
|
2002-04-09 |
2005-01-12 |
Astex Technology Limited |
Heterocyclic compounds and their use as modulators of p38 map kinase
|
|
UA78999C2
(en)
|
2002-06-04 |
2007-05-10 |
Wyeth Corp |
1-(aminoalkyl)-3-sulfonylazaindoles as ligands of 5-hydroxytryptamine-6
|
|
JP4570955B2
(ja)
|
2002-07-09 |
2010-10-27 |
バーテクス ファーマスーティカルズ インコーポレイテッド |
プロテインキナーゼ阻害活性を持つイミダゾール類
|
|
TW200403243A
(en)
|
2002-07-18 |
2004-03-01 |
Wyeth Corp |
1-Heterocyclylalkyl-3-sulfonylazaindole or-azaindazole derivatives as 5-hydroxytryptamine-6 ligands
|
|
TWI329112B
(en)
|
2002-07-19 |
2010-08-21 |
Bristol Myers Squibb Co |
Novel inhibitors of kinases
|
|
US6878887B2
(en)
|
2002-08-07 |
2005-04-12 |
Matsushita Electric Industrial Co., Ltd. |
Anti-malfunction mechanism for variable output device
|
|
EP1388341A1
(en)
|
2002-08-07 |
2004-02-11 |
Aventis Pharma Deutschland GmbH |
Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals
|
|
EP1388541A1
(en)
|
2002-08-09 |
2004-02-11 |
Centre National De La Recherche Scientifique (Cnrs) |
Pyrrolopyrazines as kinase inhibitors
|
|
SE0202463D0
(sv)
|
2002-08-14 |
2002-08-14 |
Astrazeneca Ab |
Novel compounds
|
|
KR20120104412A
(ko)
|
2002-09-06 |
2012-09-20 |
인설트 테라페틱스, 인코퍼레이티드 |
공유결합된 치료제 전달을 위한 사이클로덱스트린-기초 중합체
|
|
US20040142864A1
(en)
|
2002-09-16 |
2004-07-22 |
Plexxikon, Inc. |
Crystal structure of PIM-1 kinase
|
|
US6766199B2
(en)
|
2002-10-10 |
2004-07-20 |
Proventure (Far East), Limited |
Skin/hair treatment method and system
|
|
US7183241B2
(en)
|
2002-10-15 |
2007-02-27 |
Exxonmobil Research And Engineering Company |
Long life lubricating oil composition with very low phosphorus content
|
|
GB0226370D0
(en)
|
2002-11-12 |
2002-12-18 |
Novartis Ag |
Organic compounds
|
|
SE0203654D0
(sv)
|
2002-12-09 |
2002-12-09 |
Astrazeneca Ab |
New compounds
|
|
CA2509711A1
(en)
|
2002-12-13 |
2004-07-01 |
Smithkline Beecham Corporation |
Piperidine derivatives as ccr5 antagonists
|
|
AU2003297048A1
(en)
|
2002-12-13 |
2004-07-09 |
Smithkline Beecham Corporation |
Cyclohexyl compounds as ccr5 antagonists
|
|
UA80171C2
(en)
|
2002-12-19 |
2007-08-27 |
Pfizer Prod Inc |
Pyrrolopyrimidine derivatives
|
|
US7696225B2
(en)
|
2003-01-06 |
2010-04-13 |
Osi Pharmaceuticals, Inc. |
(2-carboxamido)(3-Amino) thiophene compounds
|
|
SE0300120D0
(sv)
|
2003-01-17 |
2003-01-17 |
Astrazeneca Ab |
Novel compounds
|
|
SE0300119D0
(sv)
|
2003-01-17 |
2003-01-17 |
Astrazeneca Ab |
Novel compounds
|
|
US20050085463A1
(en)
|
2003-01-23 |
2005-04-21 |
Weiner David M. |
Use of N-desmethylclozapine to treat human neuropsychiatric disease
|
|
CA2509958A1
(en)
|
2003-02-03 |
2004-08-19 |
Novartis Ag |
Pharmaceutical formulation
|
|
TW200418830A
(en)
|
2003-02-14 |
2004-10-01 |
Wyeth Corp |
Heterocyclyl-3-sulfonylazaindole or-azaindazole derivatives as 5-hydroxytryptamine-6 ligands
|
|
SE0300456D0
(sv)
|
2003-02-19 |
2003-02-19 |
Astrazeneca Ab |
Novel compounds
|
|
US20050170431A1
(en)
|
2003-02-28 |
2005-08-04 |
Plexxikon, Inc. |
PYK2 crystal structure and uses
|
|
US7432375B2
(en)
|
2003-03-06 |
2008-10-07 |
Eisai R & D Management Co., Ltd. |
JNK inhibitors
|
|
EP1628975A2
(en)
|
2003-05-16 |
2006-03-01 |
Eisai Co., Ltd. |
Jnk inhibitors
|
|
EP1648889B1
(en)
|
2003-07-11 |
2008-10-29 |
Warner-Lambert Company LLC |
Isethionate salt of a selective cdk4 inhibitor
|
|
CL2004001884A1
(es)
|
2003-08-04 |
2005-06-03 |
Pfizer Prod Inc |
Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros.
|
|
AR045595A1
(es)
|
2003-09-04 |
2005-11-02 |
Vertex Pharma |
Composiciones utiles como inhibidores de proteinas quinasas
|
|
WO2005044181A2
(en)
|
2003-09-09 |
2005-05-19 |
Temple University-Of The Commonwealth System Of Higher Education |
Protection of tissues and cells from cytotoxic effects of ionizing radiation by abl inhibitors
|
|
WO2005028624A2
(en)
|
2003-09-15 |
2005-03-31 |
Plexxikon, Inc. |
Molecular scaffolds for kinase ligand development
|
|
US20060281803A1
(en)
|
2003-09-23 |
2006-12-14 |
Lindsley Craig W |
Pyrazole modulators of metabotropic glutamate receptors
|
|
KR100793095B1
(ko)
|
2003-10-01 |
2008-01-10 |
주식회사 프로메디텍 |
Ｂａｃｅ 저해효능을 가진 신규한 술폰 아미드 유도체
|
|
MXPA06003996A
(es)
|
2003-10-08 |
2006-07-05 |
Irm Llc |
Compuestos y composiciones como inhibidores de la proteina cinasa.
|
|
DE10357510A1
(de)
|
2003-12-09 |
2005-07-07 |
Bayer Healthcare Ag |
Heteroarylsubstituierte Benzole
|
|
EP1696920B8
(en)
|
2003-12-19 |
2015-05-06 |
Plexxikon Inc. |
Compounds and methods for development of ret modulators
|
|
BRPI0417533B1
(pt)
|
2003-12-24 |
2016-03-01 |
Danisco |
enzima variante glicolipídio aciltransferase, uso e método para sua produção, método para o preparo de um produto alimentício e produto assado de farinha, processo de refinamento enzimático
|
|
GB0330042D0
(en)
|
2003-12-24 |
2004-01-28 |
Pharmacia Italia Spa |
Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions them
|
|
GB0330043D0
(en)
|
2003-12-24 |
2004-01-28 |
Pharmacia Italia Spa |
Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions comprising them
|
|
EP1713806B1
(en)
|
2004-02-14 |
2013-05-08 |
Irm Llc |
Compounds and compositions as protein kinase inhibitors
|
|
GB0403635D0
(en)
|
2004-02-18 |
2004-03-24 |
Devgen Nv |
Pyridinocarboxamides with improved activity as kinase inhibitors
|
|
GB0405055D0
(en)
|
2004-03-05 |
2004-04-07 |
Eisai London Res Lab Ltd |
JNK inhibitors
|
|
JP2007527918A
(ja)
|
2004-03-08 |
2007-10-04 |
アムジェン インコーポレイテッド |
Ｐｐａｒガンマ活性の治療的調節
|
|
KR20050091462A
(ko)
|
2004-03-12 |
2005-09-15 |
한국과학기술연구원 |
푸로피리미딘 화합물 및 이를 포함하는 ｄｄｒ2 티로신키나아제 활성 저해제
|
|
PL2332940T3
(pl)
|
2004-03-30 |
2013-03-29 |
Vertex Pharma |
Azaindole użyteczne jako inhibitory JAK i innych kinaz białkowych
|
|
KR20070002081A
(ko)
|
2004-04-02 |
2007-01-04 |
버텍스 파마슈티칼스 인코포레이티드 |
Ｒｏｃｋ 및 기타 단백질 키나아제의 억제제로서 유용한아자인돌
|
|
US7872016B2
(en)
|
2004-05-25 |
2011-01-18 |
Yale University |
Method for treating skeletal disorders resulting from FGFR malfunction
|
|
WO2005116035A1
(en)
|
2004-05-27 |
2005-12-08 |
Pfizer Products Inc. |
Pyrrolopyrimidine derivatives useful in cancer treatment
|
|
US20090105218A1
(en)
|
2004-05-29 |
2009-04-23 |
7Tm Pharma A/S |
CRTH2 Receptor Ligands For Therapeutic Use
|
|
US20060058339A1
(en)
|
2004-06-17 |
2006-03-16 |
Ibrahim Prabha N |
Compounds modulating c-kit activity and uses therefor
|
|
US7498342B2
(en)
|
2004-06-17 |
2009-03-03 |
Plexxikon, Inc. |
Compounds modulating c-kit activity
|
|
WO2006009741A1
(en)
*
|
2004-06-23 |
2006-01-26 |
Eli Lilly And Company |
Kinase inhibitors
|
|
EP1765819B1
(en)
|
2004-06-30 |
2014-03-12 |
Vertex Pharmaceuticals Inc. |
Azaindoles useful as inhibitors of protein kinases
|
|
US7140816B2
(en)
|
2004-07-20 |
2006-11-28 |
H&S Tool, Inc. |
Multi-functional tube milling head
|
|
CA2573573A1
(en)
|
2004-07-27 |
2006-02-09 |
Sgx Pharmaceuticals, Inc. |
Fused ring heterocycle kinase modulators
|
|
US7361764B2
(en)
|
2004-07-27 |
2008-04-22 |
Sgx Pharmaceuticals, Inc. |
Pyrrolo-pyridine kinase modulators
|
|
JP2008508303A
(ja)
|
2004-07-27 |
2008-03-21 |
エスジーエックス ファーマシューティカルズ、インコーポレイテッド |
ピロロ−ピリジンキナーゼモジュレーター
|
|
US7709645B2
(en)
|
2004-07-27 |
2010-05-04 |
Sgx Pharmaceuticals, Inc. |
Pyrrolo-pyridine kinase modulators
|
|
US7626021B2
(en)
|
2004-07-27 |
2009-12-01 |
Sgx Pharmaceuticals, Inc. |
Fused ring heterocycle kinase modulators
|
|
US20060024361A1
(en)
|
2004-07-28 |
2006-02-02 |
Isa Odidi |
Disintegrant assisted controlled release technology
|
|
US20090196912A1
(en)
|
2004-07-30 |
2009-08-06 |
Gpc Botech Ag |
Pyridinylamines
|
|
WO2006063167A1
(en)
|
2004-12-08 |
2006-06-15 |
Smithkline Beecham Corporation |
1h-pyrrolo[2,3-b]pyridines
|
|
ATE524467T1
(de)
|
2005-04-25 |
2011-09-15 |
Merck Patent Gmbh |
Neuartige aza-heterozyklen als kinase-inhibitoren
|
|
FR2884821B1
(fr)
|
2005-04-26 |
2007-07-06 |
Aventis Pharma Sa |
Pyrrolopyridines substitues, compositions les contenant, procede de fabrication et utilisation
|
|
KR20080027775A
(ko)
|
2005-05-17 |
2008-03-28 |
플렉시콘, 인코퍼레이티드 |
피롤(２,３-ｂ)피리딘 유도체 단백질 키나제 억제제
|
|
MX2007014619A
(es)
|
2005-05-20 |
2009-02-13 |
Vertex Pharma |
Pirrolopiridinas de utilidad como inhibidores de proteina quinasa.
|
|
CA2605764A1
(en)
|
2005-05-23 |
2006-11-30 |
Teva Pharmaceutical Industries Ltd. |
Amorphous cinacalcet hydrochloride and preparation thereof
|
|
NZ565245A
(en)
|
2005-06-21 |
2010-07-30 |
Mitsui Chemicals Inc |
Amide derivative and pesticide containing such compound
|
|
CN102603581B
(zh)
|
2005-06-22 |
2015-06-24 |
普莱希科公司 |
作为蛋白质激酶抑制剂的吡咯并[2,3-b]吡啶衍生物
|
|
DE102005034406A1
(de)
|
2005-07-22 |
2007-02-01 |
Ratiopharm Gmbh |
Neue Salze von Rosiglitazon
|
|
GB0516156D0
(en)
|
2005-08-05 |
2005-09-14 |
Eisai London Res Lab Ltd |
JNK inhibitors
|
|
US7754717B2
(en)
|
2005-08-15 |
2010-07-13 |
Amgen Inc. |
Bis-aryl amide compounds and methods of use
|
|
TW200812611A
(en)
|
2006-03-20 |
2008-03-16 |
Vertex Pharma |
Pharmaceutical compositions
|
|
US7963673B2
(en)
|
2006-05-30 |
2011-06-21 |
Finn Bruce L |
Versatile illumination system
|
|
US8461161B2
(en)
|
2006-11-15 |
2013-06-11 |
Ym Biosciences Australia Pty Ltd |
Substituted pyrazines as inhibitors of kinase activity
|
|
WO2008063888A2
(en)
|
2006-11-22 |
2008-05-29 |
Plexxikon, Inc. |
Compounds modulating c-fms and/or c-kit activity and uses therefor
|
|
GB0624084D0
(en)
|
2006-12-01 |
2007-01-10 |
Selamine Ltd |
Ramipril amino acid salts
|
|
US8093246B2
(en)
|
2006-12-14 |
2012-01-10 |
Lexicon Pharmaceuticals, Inc. |
O-linked pyrimidin-4-amine-based compounds, compositions comprising them, and methods of their use to treat cancer
|
|
WO2008079909A1
(en)
|
2006-12-21 |
2008-07-03 |
Plexxikon, Inc. |
Pyrrolo [2,3-b] pyridines as kinase modulators
|
|
PE20081581A1
(es)
*
|
2006-12-21 |
2008-11-12 |
Plexxikon Inc |
COMPUESTOS PIRROLO[2,3-b]PIRIDINAS COMO MODULADORES DE QUINASA
|
|
JP2010526848A
(ja)
|
2007-05-11 |
2010-08-05 |
エフ．ホフマン−ラ ロシュ アーゲー |
難溶性薬物用の医薬組成物
|
|
CL2008001540A1
(es)
|
2007-05-29 |
2009-05-22 |
Sgx Pharmaceuticals Inc |
Compuestos derivados de pirrolopiridinas y pirazolopiridinas; composicion farmaceutica; y uso en el tratamiento del cancer.
|
|
US20100190777A1
(en)
|
2007-07-17 |
2010-07-29 |
Plexxikon Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
|
WO2009012791A1
(en)
|
2007-07-23 |
2009-01-29 |
Pharmathen S.A. |
Pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereof
|
|
JP2009077712A
(ja)
|
2007-09-11 |
2009-04-16 |
F Hoffmann La Roche Ag |
Ｂ−Ｒａｆキナーゼ阻害剤に対する感受性についての診断試験
|
|
WO2009111280A1
(en)
|
2008-02-29 |
2009-09-11 |
Array Biopharma Inc. |
N- (6-aminopyridin-3-yl) -3- (sulfonamido) benzamide derivatives as b-raf inhibitors for the treatment of cancer
|
|
US20110003809A1
(en)
|
2008-02-29 |
2011-01-06 |
Array Biopharma Inc. |
Imidazo [4,5-b] pyridine derivatives used as raf inhibitors
|
|
TW200940539A
(en)
|
2008-02-29 |
2009-10-01 |
Array Biopharma Inc |
RAF inhibitor compounds and methods of use thereof
|
|
EP2265608A2
(en)
|
2008-02-29 |
2010-12-29 |
Array Biopharma, Inc. |
Raf inhibitor compounds and methods of use thereof
|
|
WO2009115084A2
(de)
|
2008-03-20 |
2009-09-24 |
Schebo Biotech Ag |
Neue pyrrolopyrimidin-derivate und deren verwendungen
|
|
UA103319C2
(en)
|
2008-05-06 |
2013-10-10 |
Глаксосмитклайн Ллк |
Thiazole- and oxazole-benzene sulfonamide compounds
|
|
PE20091846A1
(es)
|
2008-05-19 |
2009-12-16 |
Plexxikon Inc |
DERIVADOS DE PIRROLO[2,3-d]-PIRIMIDINA COMO MODULADORES DE CINASAS
|
|
WO2009152083A1
(en)
*
|
2008-06-10 |
2009-12-17 |
Plexxikon, Inc. |
5h-pyrr0l0 [2,3-b] pyrazine derivatives for kinase modulation, and indications therefor
|
|
WO2009152087A1
(en)
*
|
2008-06-10 |
2009-12-17 |
Plexxikon, Inc. |
Bicyclic heteroaryl compounds and methods for kinase modulation, and indications therefor
|
|
JP4884570B2
(ja)
|
2008-08-20 |
2012-02-29 |
ファイザー・インク |
ピロロ［２，３−ｄ］ピリミジン化合物
|
|
AR074199A1
(es)
|
2008-11-20 |
2010-12-29 |
Glaxosmithkline Llc |
Compuesto de 6-(4-pirimidinil)-1h-indazol, composiciones farmaceuticas que lo comprenden y su uso para preparar un medicamento util para el tratamiento o disminucion de la gravedad del cancer.
|
|
PE20120184A1
(es)
*
|
2009-03-11 |
2012-03-28 |
Plexxikon Inc |
Derivados del pirrolo[2,3-b]piridina para la inhibicion de las proteinas quinasas raf
|
|
JP2012520311A
(ja)
|
2009-03-11 |
2012-09-06 |
プレキシコン インコーポレーテッド |
Ｒａｆキナーゼの阻害のためのピロロ［２，３−ｂ］ピリジン誘導体
|
|
CR20170089A
(es)
|
2009-04-03 |
2017-07-17 |
Plexxikon Inc |
Composiciones del acido propano-1--sulfonico {3-[5-(4-cloro-fenil)-1h-pirrolo [2,3-b] piridina-3-carbonil] -2,4-difluoro-fenil}-amida y el uso de las mismas
|
|
TW201041888A
(en)
*
|
2009-05-06 |
2010-12-01 |
Plexxikon Inc |
Compounds and methods for kinase modulation, and indications therefor
|
|
US8329724B2
(en)
*
|
2009-08-03 |
2012-12-11 |
Hoffmann-La Roche Inc. |
Process for the manufacture of pharmaceutically active compounds
|
|
WO2011025947A1
(en)
*
|
2009-08-28 |
2011-03-03 |
Array Biopharma Inc. |
Raf inhibitor compounds and methods of use thereof
|
|
NZ599866A
(en)
|
2009-11-06 |
2014-09-26 |
Plexxikon Inc |
Compounds and methods for kinase modulation, and indications therefor
|
|
WO2011060216A1
(en)
*
|
2009-11-12 |
2011-05-19 |
Concert Pharmaceuticals Inc. |
Substituted azaindoles
|
|
ES2627911T3
(es)
|
2009-11-18 |
2017-08-01 |
Plexxikon, Inc. |
Derivados de N-[2-fluoro-3-(4-amino-7H-pirrolo[2,3-d]pirimidin-5-carbonil)-fenil]-4-bencenosulfonamida como moduladores de la proteína quinasa Raf para el tratamiento del cáncer
|
|
CN102753549A
(zh)
|
2009-12-23 |
2012-10-24 |
普莱希科公司 |
用于激酶调节的化合物和方法及其适应症
|
|
TWI619713B
(zh)
|
2010-04-21 |
2018-04-01 |
普雷辛肯公司 |
用於激酶調節的化合物和方法及其適應症
|
|
FR2964757B1
(fr)
|
2010-09-09 |
2013-04-05 |
Giroptic |
Dispositif optique pour la capture d'images selon un champ de 360°
|
|
WO2012037060A1
(en)
|
2010-09-13 |
2012-03-22 |
Concert Pharmaceuticals Inc. |
Substituted azaindoles
|
|
MA34948B1
(fr)
*
|
2011-02-07 |
2014-03-01 |
Plexxikon Inc |
Composes et procedes de modulation de kinase, et leurs indications
|
|
TWI558702B
(zh)
|
2011-02-21 |
2016-11-21 |
普雷辛肯公司 |
醫藥活性物質的固態形式
|
|
WO2012138809A1
(en)
|
2011-04-05 |
2012-10-11 |
Dawei Zhang |
Heterocyclic compounds as kinase inhibitors
|
|
RU2631487C2
(ru)
|
2011-05-17 |
2017-09-22 |
Плексксикон Инк. |
Модуляция киназ и показания к её применению
|
|
US20130172375A1
(en)
|
2011-12-13 |
2013-07-04 |
Hoffmann-La Roche Inc. |
Pharmaceutical composition
|
|
US9358235B2
(en)
|
2012-03-19 |
2016-06-07 |
Plexxikon Inc. |
Kinase modulation, and indications therefor
|
|
US20140303121A1
(en)
|
2013-03-15 |
2014-10-09 |
Plexxikon Inc. |
Heterocyclic compounds and uses thereof
|
|
CA2912568A1
(en)
*
|
2013-05-30 |
2014-12-04 |
Plexxikon Inc. |
Compounds for kinase modulation, and indications therefor
|
|
JP6832846B2
(ja)
|
2014-09-15 |
2021-02-24 |
プレキシコン インコーポレーテッドＰｌｅｘｘｉｋｏｎ Ｉｎｃ． |
ヘテロ環化合物およびその用途
|